Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
FENICSBIO CORP NCI-H929/GFP STABLE CELL LINE
Supplier: FENICSBIO CORP CL1643
NCI-H929/GFP cells are derived from the human B lymphocyte NCI-H929 cell line by stably integration of a constitutive GFP stably expression construct. NCI-H929 cells stably express B cell maturation antigen (BCMA)-a novel treatment target for multiple myeloma (MM), and have been widely used in cancer research and drug development. NCI-H929/GFP cells stably stably expressGFP, can be used for in vitro assays and in vivo imaging.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?